
Laurel Lee Periodic Transaction Report
Filed May 25, 2024 · House Clerk · 1 transaction
U.S. Representative · R · FL-15 · All trades by Laurel Lee
On May 25, 2024, Rep. Laurel Lee (R-FL-15) filed a periodic transaction report with the House Clerk disclosing 1 transaction (1 purchase) dated May 6, 2024.
The one asset reported, TuHURA Biosciences, Inc., is listed without a stock ticker. The filer coded it as "Corporate Securities (Bonds and Notes)" on the House form.
Reported amount ranges sum to $100K–$250K. Congress reports trade sizes in ranges, not exact figures.
Every trade was reported within the STOCK Act's 45-day window. The longest lag in this filing was 19 days.
1 transaction was reported under a spouse, dependent child, or joint account rather than the member directly.
Source document: House Clerk filing 20025116
Sample · the intelligence layer
Laurel Lee · Bought · May 6 · $100K–$250K
Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →
Follow Laurel Lee
Get an email the moment Laurel Lee files the next one. Free, no card, no spam.
Transactions disclosed
| Trade date | Ticker | Asset | Type | Owner | Amount | Lag |
|---|---|---|---|---|---|---|
| May 6, 2024 | — | TuHURA Biosciences, Inc. Corporate Securities (Bonds and Notes) | buy | Spouse | $100K–$250K | 19d |
The line under an asset name is the asset type the filer selected on the House form, shown with the House Clerk's label for that code. It is the filer's coding, not a classification by Coldpine.
Other recent filings by Laurel Lee
- PTR filed Oct 16, 20262 trades · BAC, NOKBF
- PTR filed Jul 19, 20266 trades · NOK, BAC, GE
- PTR filed Aug 11, 20252 trades · BABA, WBD
- PTR filed Aug 9, 20251 trade · HURA
- PTR filed Jun 22, 20251 trade · NVO
- PTR filed Jan 7, 20252 trades · HURA, WBD
← All congressional filings, newest firstFiled May 25, 2024May 2024 archive
From Coldpine Research
Data parsed from the public STOCK Act filing linked above. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. Nothing here is a recommendation. See scores and Coldpine's read on every trade, free with an account →